Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/14/15  and contains information from public web pages and contributions from the ZoomInfo community.


Web References
Ellen ..., 28 Mar 2012 [cached]
Ellen Aasum Cardiovascular Research Group Faculty of Health Sciences, University of Tromsø, Norway
Correspondence: Ellen Aasum, Cardiovascular Research Group, Institute of Medical Biology, Faculty of Health Sciences, University of Tromsø, N-9037 Tromsø, Norway. Tel: +47 77646486; fax: +47 77645440; e-mail:
BioExchange - Life Sciences and Biotechnology Resource for e-business services, career and employement services, e-commerce solutions., 4 Nov 2002 [cached]
"Hearts from diabetic db/db mice, a model of type 2 diabetes, exhibit left ventricular failure and altered metabolism of exogenous substrates," explained Ellen Aasum and colleagues at the University of Tromso in Norway.
The investigators treated 8-week-old db/db mice with 25 to 38 mg/kg per day of the PPAR-alpha ligand, BM 17.0744, for 4 to 6 weeks, and measured the effect of treatment on cardiac function and metabolism.
The elevated concentrations of glucose (34.0 mM), fatty acids (2.0 mM), and triglycerides (0.9 mM) found at the beginning of treatment dropped to normal levels after BM 17.0744 therapy (10.8, 1.1, and 0.6 mM, respectively).Mice that received BM 17.0744 also had significantly lower levels of plasma insulin than did control mice.
Fatty acid oxidation dropped by 50% in mice that had undergone long-term BM 17.0744 treatment, resulting in a 1.7-fold increase in glycolysis and 2.3-fold increase in glucose oxidation.
The corresponding author for this study is Ellen Aasum, University of Tromso, Faculty of Medicine, Institute of Medical Biology, Department of Medical Physiology, N-9037 Tromso, Norway.E-mail:
A search at using the search term "type 2 diabetes therapy" yielded 146 articles in 22 specialized reports.
Key points reported in this study include:
• Elevated levels of glucose, fatty acids, and triglycerides found in diabetic db/db mice were normalized by treatment with BM 17.0744, a novel peroxisome proliferator-activated receptor-alpha (PPAR-alpha) ligand
Other People with the name "Aasum":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.